Binkow & Goldberg LLP reminds investors of PDL
BioPharma, Inc. (“PDL BioPharma” or the “Company”) (NASDAQ:PDLI)
that those who purchased or otherwise acquired PDL BioPharma securities
between November 6, 2013 and September 16, 2014, inclusive (the “Class
Period”), have until November 17, 2014, to file a motion to be appointed
as lead plaintiff in the shareholder lawsuit filed in the United States
District Court for the District of Nevada.
for - INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against PDL BioPharma, Inc. investment picks